Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 2/20 | 0.60 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.60 |
| ▸ | OSBP | P22059 | 1/20 | 0.60 |
| ▸ | RORC | P51449 | 1/20 | 0.60 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.60 |
| ▸ | POLA1 | P09884 | 1/20 | 0.57 |
| ▸ | GRIN1 | Q05586 | 13/20 | 0.56 |
| ▸ | GRIN2B | Q13224 | 13/20 | 0.56 |
| ▸ | GRIN2A | Q12879 | 11/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL743933 | 0.94 | USP2 (0.61) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL8159169 | 0.91 | OSBP (0.65) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL6816995 | 0.88 | USP2 (0.57) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL12274582 | 0.88 | USP2 (0.61) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL565022 | 0.88 | USP2 (0.58) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL3971279 | 0.88 | USP2 (0.58) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL2638134 | 0.87 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL27975861 | 0.87 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL6060845 | 0.87 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP | |
| SCHEMBL27963054 | 0.87 | USP2 (0.68) | USP2CYP46A1LMNAABCB1OSBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3100719-A2 | DELIVERY OF NUCLEIC ACID-LIKE COMPOUNDS | California Pacific Medical Center (US) | 2016-12-07 | — | — | EP | disclosed |
| EP-1509203-B1 | DELIVERY OF NUCLEIC ACID-LIKE COMPOUNDS | CALIFORNIA PACIFIC MED CENTER (US) | 2016-04-13 | — | — | EP | disclosed |
| US-20150140069-A1 | DELIVERY OF NUCLEIC ACID-LIKE COMPOUNDS | SUTTER WEST BAY HOSPITAL DBA CALIFORNIA PACIFIC MEDICAL CT (US) | 2015-05-21 | — | — | US | disclosed |
| US-8883200-B2 | Delivery of nucleic acid-like compounds | SUTTER WEST BAY HOSPITALS (US) | 2014-11-11 | — | — | US | disclosed |
| US-20140017300-A1 | DELIVERY OF NUCLEIC ACID-LIKE COMPOUNDS | Sutter West bay Hospital, DBA California Pacific Medical Center (US) | 2014-01-16 | — | — | US | disclosed |
| US-8496961-B2 | Delivery of nucleic acid-like compounds | Sutter West Bay Hospital (US) | 2013-07-30 | — | — | US | disclosed |
| US-20090171077-A1 | DELIVERY OF NUCLEIC ACID-LIKE COMPOUNDS | CALIFORNIA PACIFIC MEDICAL CENTER | 2009-07-02 | — | — | US | disclosed |
| EP-1509203-A2 | DELIVERY OF NUCLEIC ACID-LIKE COMPOUNDS | California Pacific Medical Center (US) | 2005-03-02 | — | — | EP | disclosed |
| US-20040037874-A1 | Forming microparticulate complex that comprises particle forming component complexed to a nucleic acid-like component forming a spherical particle; drug delivery | SUTTER WEST BAY HOSPITALS, DBA CALIFORNIA PACIFIC MEDICAL CENTER | 2004-02-26 | — | — | US | disclosed |
| WO-2003097805-A2 | DELIVERY OF NUCLEIC ACID-LIKE COMPOUNDS | CALIFORNIA PACIFIC MEDICAL CENTER (US) | 2003-11-27 | — | — | WO | disclosed |